| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $126,361,072 ) (Continued on the next page) |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08DK132413 | Lymphatic-adipocyte interactions in obesity and lymphedema | 000 | 1 | NIH | 5/16/2022 | $164,484 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08CA271949 | Evaluation of triage strategies and screening intervals in a human papillomavirus based cervical cancer screening program in women living with human immunodeficiency virus in Botswana | 000 | 1 | NIH | 6/29/2022 | $258,557 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK128406 | The role of interferon regulatory factors in tanycytes during HFD-induced inflammation, obesity and glucose dysregulation | 000 | 1 | NIH | 5/12/2022 | $574,481 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HD088695 | Longitudinal trajectories of early childhood respiratory symptomatology and their impact on behavioral development | 000 | 5 | NIH | 7/12/2022 | $151,102 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01AG057836 | Shared Pathophysiology of Postoperative Delirium and Alzheimer's Disease and Related Dementias | 000 | 5 | NIH | 3/21/2022 | $116,886 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK106210 | Mechanisms for regulation of a novel class of anti-diabetic lipids | 000 | 7 | NIH | 4/14/2022 | $760,278 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K24HL127101 | Thaimine as an adjunct metabolic resuscitator in cardiac arrest | 000 | 8 | NIH | 8/22/2022 | $121,238 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI136924 | Phosphatases in Systemic Autoimmunity | 000 | 5 | NIH | 8/11/2022 | $437,500 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08HL145019 | CYP1 Inhibition as a New Therapeutic Strategy for Doxorubicin Cardiomyopathy | 000 | 4 | NIH | 1/11/2022 | $167,400 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01DK114329 | The interaction between mechanical forces and cytoskeletal impairments in podocyte mediated kidney disease | 000 | 5 | NIH | 7/26/2022 | $150,736 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI148161 | T cells in Lupus | 000 | 3 | NIH | 12/1/2021 | $437,500 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08DK115883 | Adenosine deaminase 2 regulates macrophage phenotype and liver fibrosis in nonalcoholic fatty liver disease | 000 | 5 | NIH | 7/28/2022 | $167,400 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AR062173 | The IL-23/IL-17 Axis in Inflammatory Arthritis | 003 | 8 | NIH | 11/29/2021 | $71,575 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AR062173 | The IL-23/IL-17 Axis in Inflammatory Arthritis | 002 | 8 | NIH | 11/24/2021 | $479,346 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AR062173 | The IL-23/IL-17 Axis in Inflammatory Arthritis | 009 | 8 | NIH | 8/5/2022 | $47,932 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01DK128075 | Mechanisms for the regulation of novel lipids in vivo | 000 | 2 | NIH | 4/28/2022 | $150,736 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI154860 | De Novo Synthesis, and Functional and Structural Characterization of Novel Aminoglycoside Analogues to Bypass Resistance Mechanisms and Optimize Selectivity | 000 | 3 | NIH | 8/2/2022 | $765,318 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK133948 | CalR: A toolkit and repository for experiments of energy homeostasis using indirect calorimetry | 000 | 1 | NIH | 12/30/2021 | $432,250 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK130929 | Corticosteroids to Reduce Inflammation in Severe Pancreatitis (CRISP) | 001 | 1 | NIH | 12/15/2021 | $0 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK130929 | Corticosteroids to Reduce Inflammation in Severe Pancreatitis (CRISP) | 000 | 1 | NIH | 12/14/2021 | $380,380 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK125283 | Mitochondrial BCAA transporter in physiology and disease | 000 | 2 | NIH | 11/25/2021 | $409,501 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK125283 | Mitochondrial BCAA transporter in physiology and disease | 001 | 2 | NIH | 3/28/2022 | $45,499 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG070077 | Neurobiological mechanisms of altered cortical plasticity in Type-2 diabetes mellitus | 001 | 2 | NIH | 6/13/2022 | $85,747 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG070077 | Neurobiological mechanisms of altered cortical plasticity in Type-2 diabetes mellitus | 000 | 2 | NIH | 2/7/2022 | $771,696 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01ES031252 | A Randomized Controlled Trial of Home Air Purification for Eosinophilic COPD | 000 | 3 | NIH | 2/24/2022 | $756,361 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01GM140201 | Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System | 000 | 2 | NIH | 7/27/2022 | $499,122 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK125846 | Characterizing the role of the heme catabolism in tissue damage and inflammation. | 001 | 2 | NIH | 3/30/2022 | $52,360 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK125846 | Characterizing the role of the heme catabolism in tissue damage and inflammation. | 000 | 2 | NIH | 2/28/2022 | $471,245 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG065311 | A Conversation Aid on Mammography Screening to Support Shared Decision Making between Clinicians and Women Aged 75 and Older | 001 | 3 | NIH | 4/22/2022 | $59,275 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG065311 | A Conversation Aid on Mammography Screening to Support Shared Decision Making between Clinicians and Women Aged 75 and Older | 000 | 3 | NIH | 12/1/2021 | $533,483 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA241194 | Targeting microRNAs in the tumor microenvironment with pHLIP conjugated next generation chemically modified PNAs | 001 | 3 | NIH | 4/25/2022 | $30,746 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA241194 | Targeting microRNAs in the tumor microenvironment with pHLIP conjugated next generation chemically modified PNAs | 000 | 3 | NIH | 1/7/2022 | $345,869 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HL150290 | Shared Decision-Making to Improve the Health Status of Patients with Claudication: Developing and Implementing Strategies to Individualize Treatment Decisions | 000 | 3 | NIH | 8/17/2022 | $169,911 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA242747 | A prediction model to simultaneously estimate personal risk of breast cancer and death from other causes in women aged 55 and older | 000 | 3 | NIH | 4/19/2022 | $524,548 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HL144907 | Identification of the Components of Frailty Using Administrative Data and Metabolite Profiling | 000 | 4 | NIH | 7/1/2022 | $172,800 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23AG068364 | Understanding the structural, functional, and prognostic implications of cortical excitability in Alzheimer's disease | 000 | 2 | NIH | 6/1/2022 | $165,020 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23AG068364 | Understanding the structural, functional, and prognostic implications of cortical excitability in Alzheimer's disease | 001 | 2 | NIH | 9/7/2022 | $54,000 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01EY032749 | State-dependent modulation of retinothalamic axonal boutons | 000 | 2 | NIH | 5/13/2022 | $426,315 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI149670 | Single-Cell Analysis of the HIV/SIV Reservoir | 000 | 3 | NIH | 6/3/2022 | $821,117 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI085567 | Expanded Double Negative T cells in SLE. | 000 | 12 | NIH | 5/11/2022 | $504,820 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R61DK131915 | Proteomic Biomarkers Prognostic for Diabetic Wound Healing | 000 | 1 | NIH | 4/22/2022 | $568,660 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23MH127464 | The Impact of Insufficient Sleep and Insomnia Disorder on Behavioral and Neural Markers of Emotion Regulation | 000 | 1 | NIH | 6/14/2022 | $152,551 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA177910 | Novel regulation of PI3K/Akt to direct targeted breast cancer therapies | 001 | 9 | NIH | 4/25/2022 | $15,438 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA177910 | Novel regulation of PI3K/Akt to direct targeted breast cancer therapies | 000 | 9 | NIH | 2/21/2022 | $391,875 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA249223 | Pentraxin-3 in the Pathogenesis and Management of Triple-Negative Breast Cancer | 000 | 2 | NIH | 7/11/2022 | $441,137 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK123002 | Function of LRP1 in regulating A? clearance in choroid plexus. | 001 | 3 | NIH | 8/23/2022 | $432,250 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK123002 | Function of LRP1 in regulating A? clearance in choroid plexus. | 000 | 3 | NIH | 5/10/2022 | $494,405 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | T32HL155020 | Training Program in Resuscitation Science | 001 | 2 | NIH | 6/30/2022 | $15,667 |
| | 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | T32HL155020 | Training Program in Resuscitation Science | 000 | 2 | NIH | 1/10/2022 | $337,810 |
|
